MEDICINOVA, INC. Property, Plant and Equipment, Gross
MEDICINOVA, INC. (MNOV) had Property, Plant and Equipment, Gross of $431.15 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-10
- 2025-12-31: Property, Plant and Equipment, Gross $431.15K.
- 2024-12-31: Property, Plant and Equipment, Gross $428.24K.
- 2023-12-31: Property, Plant and Equipment, Gross $489.31K.
- 2022-12-31: Property, Plant and Equipment, Gross $478.07K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $431.15K 10-K · filed 2026-03-10 |
| 2024-12-31 | $428.24K 10-K · filed 2026-03-10 |
| 2023-12-31 | $489.31K 10-K · filed 2025-02-19 |
| 2022-12-31 | $478.07K 10-K · filed 2024-02-15 |
| 2021-12-31 | $482.77K 10-K/A · filed 2023-03-28 |
| 2020-12-31 | $579.32K 10-K · filed 2022-02-16 |
| 2019-12-31 | $538.41K 10-K · filed 2021-02-19 |
| 2018-12-31 | $536.66K 10-K · filed 2020-02-13 |
| 2017-12-31 | $534.60K 10-K · filed 2019-02-13 |
| 2016-12-31 | $590.12K 10-K · filed 2018-02-13 |
| 2015-12-31 | $503.67K 10-K · filed 2017-02-14 |
| 2014-12-31 | $506.79K 10-K · filed 2016-02-25 |
| 2013-12-31 | $513.61K 10-K · filed 2015-03-12 |
| 2012-12-31 | $750.77K 10-K · filed 2014-03-27 |
| 2011-12-31 | $955.36K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |